Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy

The purpose of this study is to determine whether continuous intravenous ketorolac infusion reduces pain in patients who are having laparoscopic surgery to donate a kidney.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Nephrectomy Laparoscopic Donor Nephrectomy

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Mayo Clinic

Phoenix, Arizona, 85054, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients donating a kidney via laparoscopic donor nephrectomy

Exclusion criteria

History of NSAID allergy
Asthma
History of long term opioid use
Intraoperative blood loss greater than 300 mL
Postoperative hemodynamic instability
Active peptic ulcer disease
Advanced renal impairment (Cr > 2.0 mg/dL)
Bleeding diathesis
Current use of probenecid
Pregnancy

Treatment and study plan

Ketorolac

Drug

90 mg ketorolac in 1 L of normal saline infused at 40-120 mL/hr for 18.5-23 hours beginning 0.5 hours after the end of surgery.

Other names: Toradol, Acular

Placebo

Drug

1 L of normal saline infused at 40-120 mL/hr for 18.5-23 hours beginning 0.5 hours after the end of surgery.

Primary outcomes

Pain 'Right Now'

Time frame: 24 hours after the end of surgery

Visual analog scale score for pain on a scale from 0 = None to 10 = Worst.
Morphine Equivalents of Concomitant Pain Medication

Time frame: 24 hours after the end of surgery

The morphine equivalent is a unit of measure to compare the efficacy of different types of opioids (narcotics). The patients were allowed to take additional pain medication in addition to either study drug or placebo. This outcome measure reports the amount of morphine (in mg) equivalent to the amount of concomitant pain medication used by the patient.

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

The Efficacy of Continuous Intravenous Ketorolac for Postoperative Pain in Laparoscopic Donor Nephrectomy: a Double Blinded Randomized Placebo Controlled Trial.

Important dates

Study start: 2008
Primary completion: 2010
Study completion: 2010
First posted: Oct 2, 2008
Registry last updated: Jan 27, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed